Order Information
Contact us
Insert title here
Featured Products
HY-10005  |  Flavopiridol
HY-10008  |  SNS-032
HY-10012  |  AZD-5438
HY-10014  |  R547
HY-10032  |  PF 477736
HY-10087  |  Navitoclax
HY-10128  |  ZM-447439
HY-10161  |  Tozasertib
HY-10180  |  MLN8054
HY-10192  |  NVP-TAE 684
HY-10228  |  Motesanib
HY-10249  |  GSK-690693
HY-10355  |  AKT inhibitor VIII
HY-10358  |  MK 2206 (dihydrochloride)
HY-10992  |  AZD-7762
HY-10997  |  PCI-32765
HY-11001  |  PHA-793887
HY-11002  |  CP-466722
HY-11007  |  GNF-2
HY-11009  |  CGP60474


 (Synonyms  MK-0457;VX 680)
639089-54-6  Technical Data: Price and Availability of  Cas No:639089-54-6

Cas : 639089-54-6 M.Wt: 464.5864
Cas : 639089-54-6 Formula: C23H28N8OS
Cas : 639089-54-6 Purity: >98 %
Cas : 639089-54-6 Storage: at 20℃ 2 years
Cas : 639089-54-6 Solubility: 10 mM in DMSO
Cas : 639089-54-6 Name: Tozasertib
1g/$610 In-stock
50mg/$60 In-stock
100mg/$100 In-stock
250mg/$200 In-stock
500mg/$360 In-stock
1g Get quote
5g Get quote
>10g Get quote
We match the lowest price on market.
We offer a substantial discount on larger orders,please
inquire via sales@chemexpress.cn
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
Online Inquiry
639089-54-6  Data Sheet:
Introduction of 639089-54-6 :
Tozasertib is the inhibitor of Aurora-A, -B, -C kinases with Ki values of 0.6, 18, 4.6 nM, respectively. IC50 & Target: Ki: 0.6 nM (Aurora A), 18 nM (Aurora B), 4.6 nM (Aurora C) In Vitro: Tozasertib induces similar cytotoxicity with IC50 of approximately 300 nM and exhibits an AUR B-like inhibitory phenotype of G2/M arrest, endoreduplication and apoptosis in BaF3 cells transfected with ABL or FLT-3 (mutant and wild type) kinases. Tozasertib prevents the CAL-62 proliferation in a time-dependent manner. Tozasertib treatment for 14 days significantly decreases the number and size of colonies by approximately 70% in the 8305C and 90% in the CAL-62, 8505C and BHT-101. Treatment of the different ATC cells with Tozasertib inhibits proliferation with the IC50 between 25 and 150 nM. The Tozasertib significantly impairs the ability of the different cell lines to form colonies in soft agar. Analysis of caspase-3 activity indicates that Tozasertib induces apoptosis in the different cell lines. CAL-62 cells exposed for 12 hours to Tozasertib show an accumulation of cells with ≥ 4N DNA content. Time-lapse analysis demonstrates that Tozasertib-treated CAL-62 cells exit metaphase without dividing. Moreover, histone H3 phosphorylation is abrogated following Tozasertib treatment[2].?Tozasertib has significant inhibitory activity against BCR-Abl bearing the T315I mutation in patient-derived samples[3].?
References on 639089-54-6 :

Keywords: buy Tozasertib | Tozasertib Supplier | purchase Tozasertib | Tozasertib cost | Tozasertib manufacturer | order Tozasertib | Tozasertib distributor | Tozasertib structure
buy 639089-54-6 | 639089-54-6 Supplier | purchase 639089-54-6 | 639089-54-6 cost | 639089-54-6 manufacturer | order 639089-54-6 | 639089-54-6 distributor | 639089-54-6 structure
Insert title here
Products are for research use only. Not for human use. We do not sell to patients.           Copyright © 2009 Haoyuan Chemexpress All Rights Reserved
ADDRESS: 6/F, No. 2 Building, No. 720,Cailun Road, Shanghai, P.R.China  
86-21-58998590   FAX: 86-21-53700326, 86-21-58998590   E-mail: sales@chemexpress.cn